Emergent Biosolutions: 52-Week High Recently Eclipsed (EBS)
Shares of Emergent Biosolutions (NYSE:EBS) traded today at $40.96, breaking its 52-week high. So far today approximately 90,000 shares have been exchanged, as compared to an average 30-day volume of 421,000 shares.
Emergent Biosolutions share prices have moved between a 52-week high of $40.96 and a 52-week low of $27.68 and are now trading 46% above that low price at $40.35 per share. The 200-day and 50-day moving averages have moved 0.32% higher and 0.96% higher over the past week, respectively.
There is potential upside of 5.3% for shares of Emergent Biosolutions based on a current price of $40.35 and an average consensus analyst price target of $42.50. The stock should discover initial support at its 50-day moving average (MA) of $36.36 and subsequent support at its 200-day MA of $34.81.
Emergent Biosolutions, Inc. develops and produces immunobiotics, pharmaceutical products that assist the body's immune system to prevent or treat disease. The Company produces a vaccine for anthrax.
SmarTrend recommended that subscribers consider buying shares of Emergent Biosolutions on March 30th, 2016 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $35.86. Since that recommendation, shares of Emergent Biosolutions have risen 13.5%. We continue to monitor EBS for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.
Keywords: 52 week high/lows emergent biosolutions